Search | Webyourself Social Media Platform

Bhavana Raja added article Health
2023-11-01 09:27:36 -

Duchenne Muscular Dystrophy (DMD) Treatment Market Trends and Segments Forecast To 2029
The global duchenne muscular dystrophy (dmd) treatment market size was valued at USD 3.8 billion in 2022 and is poised to grow at a significant CAGR of 38.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth...

0 Comments 0 Shares 1279 Views 0 Reviews

Please log in to like, share and comment!
Biswajit Swain added article Other
2024-10-03 09:24:43 -

Duchenne Muscular Dystrophy Market Analysis, Report, Trends & Forecast
According to the UnivDatos Market Insights analysis, advancements in genetic research, growing awareness campaigns, and advocacy efforts, regulatory agencies and pharmaceutical companies increasingly prioritize patient input in the drug development process, which will drive the 7MM scenario of the Duchenne Muscular Dystrophy Market. As per their “Duchenne Muscular Dystrophy Market”...

0 Comments 0 Shares 173 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-23 12:19:35 -

A New Era in Duchenne Muscular Dystrophy: Inside Sarepta’s ELEVIDYS Therapy
Sarepta Therapeutics has ushered in a new chapter in the treatment of Duchenne Muscular Dystrophy (DMD) with the introduction of ELEVIDYS (delandistrogene moxeparvovec-rokl), the first gene therapy approved for this devastating disorder. With the U.S. Food and Drug Administration (FDA) granting accelerated approval in June 2023, ELEVIDYS offers hope by addressing the root cause of DMD....

0 Comments 0 Shares 102 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-17 11:01:24 -

Breaking Barriers: Innovative Approaches to Treat Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration, primarily affecting boys. While a definitive cure remains elusive, groundbreaking innovations in research and treatment are breaking barriers and providing new hope for patients and their families. This article highlights some of the most promising approaches currently being...

0 Comments 0 Shares 144 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-22 10:52:43 -

Duchenne Muscular Dystrophy Market: What's More Beyond Exon-Skipping Therapies?
Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration, primarily affecting young boys. The market for DMD therapeutics has made significant strides in recent years, particularly with the advent of exon-skipping therapies. However, the quest to improve patient outcomes has driven researchers and pharmaceutical companies to explore...

0 Comments 0 Shares 124 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-23 09:27:06 -

Pricing and Reimbursement: Gene Therapy's Impact on Healthcare Economics
Gene therapy has emerged as a revolutionary approach to treating genetic disorders, offering potential cures where traditional therapies may only provide symptomatic relief. However, the high costs associated with these therapies have sparked significant debate regarding their pricing and reimbursement strategies. This article examines the economic implications of gene therapy, exploring the...

0 Comments 0 Shares 114 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-24 10:38:44 -

Targeting Neuromuscular Diseases with ASOs and siRNA Therapies
Neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS), involve progressive muscle degeneration and neurological impairments, posing immense challenges for patients and caregivers. However, antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) therapies offer promising solutions by targeting...

0 Comments 0 Shares 119 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-17 06:07:25 -

The Future of Duchenne Muscular Dystrophy Treatment: Hope and Innovation
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder caused by mutations in the dystrophin gene, resulting in progressive muscle degeneration. Typically diagnosed in early childhood, the condition leads to the loss of ambulation by adolescence and, without intervention, premature death due to respiratory or cardiac complications. However, recent breakthroughs in medical research and...

0 Comments 0 Shares 146 Views 0 Reviews

Please log in to like, share and comment!
Steven William added article Health
2024-10-17 09:33:43 -

The Long Road to a Cure: Current Progress Against DMD
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. Caused by mutations in the dystrophin gene, DMD leads to the absence of dystrophin, a vital protein for muscle health. Historically, DMD has posed significant challenges for both patients and researchers, with limited treatment options focused...

0 Comments 0 Shares 169 Views 0 Reviews

Please log in to like, share and comment!